Company Introduction:

Shanghai Yitian Pharmaceutical Technology Development Co., Ltd., as a third-party service platform for subject compensation and damage compensation in drug clinical trials, has been committed to developing compliant, desensitized, intelligent, process oriented, and efficient compensation solutions for clinical trial subjects since its establishment. A lot of work has been done in protecting subject information, fast payment, real-time approval, tracking and auditing, full process traceability, improving subject follow-up rates, and reducing dropout rates. The entire process complies with the relevant provisions of GCP, making a contribution to accelerating the progress of clinical trials and protecting the rights and interests of subjects. We have successfully provided compensation services to over 400 sponsors, over 200 GCP institutions, and more than 20000 participants in clinical trials, covering over 500 clinical trial projects. We have also provided emergency prepayment services for some special projects, which have received praise from numerous institutions, sponsors, and CRO companies. Yitian has also become the first participant compensation rights protection service platform recommended by the China Clinical Research Capability Enhancement and Subject Protection Association (CCHRPP); Listed as the Collaborative Innovation Project of Shanghai Jiao Tong University School of Medicine (TM202116PT) and Shanghai Shenkang Medical Enterprise Integration Innovation Special Support (SHDC2022CRS032).

As a completely independent third-party service organization, the company is not affiliated with any interested sponsors, CRO companies, or SMO companies. It adheres to laws and regulations and strictly implements subject information protection. The service platform has obtained the Information Level Protection Certificate from the Ministry of Public Security, the Computer Software Copyright Registration Certificate from the National Copyright Administration, and relevant security evaluation and testing reports. The entire process complies with the relevant provisions of GCP and the requirements of the tax department.

Business Introduction: